Literature DB >> 22095726

Pressure-overload-induced subcellular relocalization/oxidation of soluble guanylyl cyclase in the heart modulates enzyme stimulation.

Emily J Tsai1, Yuchuan Liu, Norimichi Koitabashi, Djahida Bedja, Thomas Danner, Jean-Francois Jasmin, Michael P Lisanti, Andreas Friebe, Eiki Takimoto, David A Kass.   

Abstract

RATIONALE: Soluble guanylyl cyclase (sGC) generates cyclic guanosine monophophate (cGMP) upon activation by nitric oxide (NO). Cardiac NO-sGC-cGMP signaling blunts cardiac stress responses, including pressure-overload-induced hypertrophy. The latter itself depresses signaling through this pathway by reducing NO generation and enhancing cGMP hydrolysis.
OBJECTIVE: We tested the hypothesis that the sGC response to NO also declines with pressure-overload stress and assessed the role of heme-oxidation and altered intracellular compartmentation of sGC as potential mechanisms. METHODS AND
RESULTS: C57BL/6 mice subjected to transverse aortic constriction (TAC) developed cardiac hypertrophy and dysfunction. NO-stimulated sGC activity was markedly depressed, whereas NO- and heme-independent sGC activation by BAY 60-2770 was preserved. Total sGCα(1) and β(1) expression were unchanged by TAC; however, sGCβ(1) subunits shifted out of caveolin-enriched microdomains. NO-stimulated sGC activity was 2- to 3-fold greater in Cav3-containing lipid raft versus nonlipid raft domains in control and 6-fold greater after TAC. In contrast, BAY 60-2770 responses were >10 fold higher in non-Cav3 domains with and without TAC, declining about 60% after TAC within each compartment. Mice genetically lacking Cav3 had reduced NO- and BAY-stimulated sGC activity in microdomains containing Cav3 for controls but no change within non-Cav3-enriched domains.
CONCLUSIONS: Pressure overload depresses NO/heme-dependent sGC activation in the heart, consistent with enhanced oxidation. The data reveal a novel additional mechanism for reduced NO-coupled sGC activity related to dynamic shifts in membrane microdomain localization, with Cav3-microdomains protecting sGC from heme-oxidation and facilitating NO responsiveness. Translocation of sGC out of this domain favors sGC oxidation and contributes to depressed NO-stimulated sGC activity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22095726      PMCID: PMC4264382          DOI: 10.1161/CIRCRESAHA.111.259242

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  51 in total

1.  Guanylyl cyclase/PSD-95 interaction: targeting of the nitric oxide-sensitive alpha2beta1 guanylyl cyclase to synaptic membranes.

Authors:  M Russwurm; N Wittau; D Koesling
Journal:  J Biol Chem       Date:  2001-09-25       Impact factor: 5.157

2.  Calcium-dependent membrane association sensitizes soluble guanylyl cyclase to nitric oxide.

Authors:  Ulrike Zabel; Christoph Kleinschnitz; Phil Oh; Pavel Nedvetsky; Albert Smolenski; Helmut Müller; Petra Kronich; Peter Kugler; Ulrich Walter; Jan E Schnitzer; Harald H H W Schmidt
Journal:  Nat Cell Biol       Date:  2002-04       Impact factor: 28.824

3.  Cardiac-specific overexpression of caveolin-3 attenuates cardiac hypertrophy and increases natriuretic peptide expression and signaling.

Authors:  Yousuke T Horikawa; Mathivadhani Panneerselvam; Yoshitaka Kawaraguchi; Yasuo M Tsutsumi; Sameh S Ali; Ravi C Balijepalli; Fiona Murray; Brian P Head; Ingrid R Niesman; Timo Rieg; Volker Vallon; Paul A Insel; Hemal H Patel; David M Roth
Journal:  J Am Coll Cardiol       Date:  2011-05-31       Impact factor: 24.094

4.  Novel complexes of guanylate cyclase with heat shock protein 90 and nitric oxide synthase.

Authors:  Richard C Venema; Virginia J Venema; Hong Ju; M Brennan Harris; Connie Snead; Tamas Jilling; Christiana Dimitropoulou; Michael E Maragoudakis; John D Catravas
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-04-03       Impact factor: 4.733

5.  The primary structure of the 70 kDa subunit of bovine soluble guanylate cyclase.

Authors:  D Koesling; J Herz; H Gausepohl; F Niroomand; K D Hinsch; A Mülsch; E Böhme; G Schultz; R Frank
Journal:  FEBS Lett       Date:  1988-10-24       Impact factor: 4.124

6.  cGMP-dependent protein kinase I mediates the negative inotropic effect of cGMP in the murine myocardium.

Authors:  Jörg W Wegener; Hermann Nawrath; Wiebke Wolfsgruber; Susanne Kühbandner; Claudia Werner; Franz Hofmann; Robert Feil
Journal:  Circ Res       Date:  2002-01-11       Impact factor: 17.367

7.  Association of soluble guanylate cyclase with the sarcolemma of mammalian skeletal muscle fibers.

Authors:  M Feussner; H Richter; O Baum; R Gossrau
Journal:  Acta Histochem       Date:  2001-07       Impact factor: 2.479

8.  Cytokine-induced nitric oxide production inhibits mitochondrial energy production and impairs contractile function in rat cardiac myocytes.

Authors:  T Tatsumi; S Matoba; A Kawahara; N Keira; J Shiraishi; K Akashi; M Kobara; T Tanaka; M Katamura; C Nakagawa; B Ohta; T Shirayama; K Takeda; J Asayama; H Fliss; M Nakagawa
Journal:  J Am Coll Cardiol       Date:  2000-04       Impact factor: 24.094

9.  Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade.

Authors:  Scott E Woodman; David S Park; Alex W Cohen; Michelle W-C Cheung; Madhulika Chandra; Jamshid Shirani; Baiyu Tang; Linda A Jelicks; Richard N Kitsis; George J Christ; Stephen M Factor; Herbert B Tanowitz; Michael P Lisanti
Journal:  J Biol Chem       Date:  2002-07-23       Impact factor: 5.157

10.  Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities.

Authors:  F Galbiati; J A Engelman; D Volonte; X L Zhang; C Minetti; M Li; H Hou; B Kneitz; W Edelmann; M P Lisanti
Journal:  J Biol Chem       Date:  2001-03-19       Impact factor: 5.157

View more
  34 in total

1.  Attenuated response of L-type calcium current to nitric oxide in atrial fibrillation.

Authors:  Nadiia Rozmaritsa; Torsten Christ; David R Van Wagoner; Hannelore Haase; Johannes-Peter Stasch; Klaus Matschke; Ursula Ravens
Journal:  Cardiovasc Res       Date:  2013-12-12       Impact factor: 10.787

Review 2.  Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies.

Authors:  Kavita Sharma; David A Kass
Journal:  Circ Res       Date:  2014-06-20       Impact factor: 17.367

3.  Caveolin-3 Overexpression Attenuates Cardiac Hypertrophy via Inhibition of T-type Ca2+ Current Modulated by Protein Kinase Cα in Cardiomyocytes.

Authors:  Yogananda S Markandeya; Laura J Phelan; Marites T Woon; Alexis M Keefe; Courtney R Reynolds; Benjamin K August; Timothy A Hacker; David M Roth; Hemal H Patel; Ravi C Balijepalli
Journal:  J Biol Chem       Date:  2015-07-13       Impact factor: 5.157

4.  Soluble guanylyl cyclase-activated cyclic GMP-dependent protein kinase inhibits arterial smooth muscle cell migration independent of VASP-serine 239 phosphorylation.

Authors:  Andrew W Holt; Danielle N Martin; Patti R Shaver; Shaquria P Adderley; Joshua D Stone; Chintamani N Joshi; Jake T Francisco; Robert M Lust; Douglas A Weidner; Brian M Shewchuk; David A Tulis
Journal:  Cell Signal       Date:  2016-06-11       Impact factor: 4.315

5.  Loss of smooth muscle CYB5R3 amplifies angiotensin II-induced hypertension by increasing sGC heme oxidation.

Authors:  Brittany G Durgin; Scott A Hahn; Heidi M Schmidt; Megan P Miller; Neha Hafeez; Ilka Mathar; Daniel Freitag; Peter Sandner; Adam C Straub
Journal:  JCI Insight       Date:  2019-10-03

Review 6.  Redox regulation of soluble guanylyl cyclase.

Authors:  Rohan C Shah; Subramaniam Sanker; Katherine C Wood; Brittany G Durgin; Adam C Straub
Journal:  Nitric Oxide       Date:  2018-03-22       Impact factor: 4.427

Review 7.  cGMP: transition from bench to bedside: a report of the 6th International Conference on cGMP Generators, Effectors and Therapeutic Implications.

Authors:  Linda S Hoffmann; Horng H Chen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-06-15       Impact factor: 3.000

8.  Prevention of PKG-1α Oxidation Suppresses Antihypertrophic/Antifibrotic Effects From PDE5 Inhibition but not sGC Stimulation.

Authors:  Taishi Nakamura; Guangshuo Zhu; Mark J Ranek; Kristen Kokkonen-Simon; Manling Zhang; Grace E Kim; Kenichi Tsujita; David A Kass
Journal:  Circ Heart Fail       Date:  2018-03       Impact factor: 8.790

9.  Chronic β1-adrenergic blockade enhances myocardial β3-adrenergic coupling with nitric oxide-cGMP signaling in a canine model of chronic volume overload: new insight into mechanisms of cardiac benefit with selective β1-blocker therapy.

Authors:  Danielle M Trappanese; Yuchuan Liu; Ryan C McCormick; Alessandro Cannavo; Gayani Nanayakkara; Marina M Baskharoun; Harish Jarrett; Felix J Woitek; D Michael Tillson; A Ray Dillon; Fabio A Recchia; Jean-Luc Balligand; Steven R Houser; Walter J Koch; Louis J Dell'Italia; Emily J Tsai
Journal:  Basic Res Cardiol       Date:  2014-12-06       Impact factor: 17.165

10.  Preconditioning with soluble guanylate cyclase activation prevents postischemic inflammation and reduces nitrate tolerance in heme oxygenase-1 knockout mice.

Authors:  Walter Z Wang; Allan W Jones; Meifang Wang; William Durante; Ronald J Korthuis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-06-14       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.